|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/569 | (2006.01) |
| G01N 33/574 | (2006.01) | ||
| G01N 33/68 | (2006.01) |
| (11) | Number of the document | 3628070 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18725722.5 |
| Date of filing the European patent application | 2018-04-27 | |
| (97) | Date of publication of the European application | 2020-04-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/029897 |
| Date | 2018-04-27 |
| (87) | Number | WO 2018/201014 |
| Date | 2018-11-01 |
| (30) | Number | Date | Country code |
| 201762491479 P | 2017-04-28 | US |
| (72) |
BRENNAN, Thomas , US
SENNINO, Barbara , US
BARBEE, Susannah D. , US
JEFFRY, Ursula , US
|
| (73) |
Five Prime Therapeutics, Inc. ,
111 Oyster Point Boulevard, South San Francisco, CA 94080,
US
|
| (54) | CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES FOR USE IN INCREASING CENTRAL MEMORY T CELLS |
| CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES FOR USE IN INCREASING CENTRAL MEMORY T CELLS |